Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Treatment of the agitation of late-life psychosis and Alzheimer's disease
Autore:
Salzman, C;
Indirizzi:
Harvard Univ, Sch Med, Boston, MA 02115 USA Harvard Univ Boston MA USA 02115 vard Univ, Sch Med, Boston, MA 02115 USA
Titolo Testata:
EUROPEAN PSYCHIATRY
, volume: 16, anno: 2001, supplemento:, 1
pagine: 25S - 28S
SICI:
0924-9338(200101)16:<25S:TOTAOL>2.0.ZU;2-F
Fonte:
ISI
Lingua:
ENG
Soggetto:
DONEPEZIL; PATIENT;
Keywords:
agitation; Alzheimer's; antipsychotic drugs; neuroleptics; tardive dyskinesia;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Social & Behavioral Sciences
Clinical Medicine
Citazioni:
12
Recensione:
Indirizzi per estratti:
Indirizzo: Salzman, C Harvard Univ, Sch Med, 74 Fenwood Rd, Boston, MA 02115 USA Harvard Univ 74 Fenwood Rd Boston MA USA 02115 on, MA 02115 USA
Citazione:
C. Salzman, "Treatment of the agitation of late-life psychosis and Alzheimer's disease", EUR PSYCHIA, 16, 2001, pp. 25S-28S

Abstract

In older as well as younger people, antipsychotic medication is commonly used to treat psychoses. In clinical practice, antipsychotic medication is also used to control severe behavioral disturbances such as agitation, wandering, self-mutilation, as well as assaultiveness. Neuroleptic and non-neuroleptic drug treatments are used to control severe agitation and disruptive behavior. Among typical neuroleptics, very low doses (e.g., 0.25 mg of haloperidol 1-4 times per day) may be effective and limit the development of severe extrapyramidal reactions. Recent experience suggests that the atypical neuroleptics, olanzaine, risperidone, and quetiapine, are also useful for controlling severe agitation in elderly demented nursing home residents. The benzamides are also known for the treatment of behavioral disturbancesin Europe, but there is little experience in the U.S.A. Although research studies in this area are virtually nonexistent, growing clinical experience sugests that the following may be quite useful: I)trazodone; 2) buspirone (Buspar(R)); 3) anticonvulsants (e.g., valproate); and 4) beta -blockers. (C) 2001 Editions scientifiques et medicales Elsevier SAS.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/04/20 alle ore 03:32:42